Navigation Links
DoctorDirectory to Co-market VoSpire ER(R) with DAVA Pharmaceuticals, Inc.
Date:7/29/2008

ASHEVILLE, N.C., July 29 /PRNewswire/ -- DoctorDirectory.com, Inc. announced that it is partnering with DAVA Pharmaceuticals, Inc. to co-market VoSpire ER(R) (Albuterol Sulfate) Extended-Release Tablets through its IncreaseRx(R) virtual marketing solution. IncreaseRx utilizes web-based educational and promotional tactics to reach tens of thousands of interested prescribers with targeted sales and marketing messages. Essentially, IncreaseRx performs as a virtual contract sales organization providing e-sampling and online educational tools. "Our team is looking forward to promoting VoSpire ER(R) with DAVA. Albuterol sulfate remains a standard of long-lasting oral therapy for patients," said Jay Grobowsky, CEO for DoctorDirectory.

VoSpire ER(R) is indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease.

"We at DAVA felt that the DoctorDirectory team and the IncreaseRx solution were an excellent fit for the continued promotion of VoSpire ER(R). The strength of IncreaseRx is in its ability to reach far more prescribers than we could have by utilizing a traditional sales force model. The value-based relationship that DoctorDirectory has with its physicians gives our brand a particularly attractive solution," said Liad Spiro, Senior Director, Commercialization and Marketing for DAVA.

DoctorDirectory is a marketing solutions company that specializes in providing brand teams and their agencies web-based access to Healthcare Professionals. IncreaseRx is a whitespace strategy designed to reach under-performing or inaccessible physician segments and generate incremental revenue from unrealized potential. It utilizes a suite of traditional and web-based tactics to generate incremental revenue for any pharma brand regardless of product life cycle.

For more information about DoctorDirectory or IncreaseRx, contact Jay Grobowsky at 828-255-0252 or by email at jay.grobowsky@doctordirectory.com.

DAVA Pharmaceuticals, Inc. is a global pharmaceutical company committed to providing cost-effective pharmaceutical products to the healthcare market by integrating expertise in product development, manufacturing and marketing with global strategic alliances to deliver medicines from the source.

For more information about DAVA Pharmaceuticals, Inc., contact Liad Spiro at 201-947-7442 or by email at LSpiro@davapharma.com.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE DoctorDirectory.com, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. XCPT(TM) Patient Engagement and Communication Software and DentalXP.com, a Leading Provider of Online Dental Education and Content, Sign a Co-Marketing Agreement
2. Energizer Joins Roster of Susan G. Komen Race for the Cure(R) National Sponsors; Energizer(R) ReTreat Pampers Cancer Survivors With Traveling Mini-Spa
3. Infor-Med, Inc. Announces New Praxis EMR Version 4 with The Praxis Knowledge Exchanger(R)
4. Manhattan Research: ePharma Consumer(R) Research and Advisory Service Now Available
5. FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11
6. Nano Pet Products, LLC Named Exclusive Worldwide Licensee by Schoeller(R) Technologies AG for Pet Products to Develop the Most Technologically Advanced Pet Brands on the Market Today
7. Pioneer(R) Surgical Technology, Inc. Continues to Prove Science Behind PEEK-on-PEEK(TM) Technology for Motion Preservation Devices
8. Quaker(R) Life(R) Cereal Partners with Actress and Mom Holly Robinson Peete to Inspire Moms to Make Their Best Days Happen
9. Kinetic Technologies, Makers of Conquer(R), Introduces New Website
10. CAS New SciFinder(R) Enhances the Research Experience Via the Web
11. AGA Medical Corporation Receives CE Mark Approval for the AMPLATZER(R) Vascular Plug III
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, ... June: From Not to Hot,” which will begin airing on February 24, 2017. The ... millions from the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, ... relations, content marketing, social media management, corporate communications, SEO and cause marketing, is ... and in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April ... diverse symposium on “Doping in Sport: How the Culture Might Change,” ... Hampton LLP. The symposium will be held at Pepperdine University in Malibu, California. ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... an exciting, new, interactive publication where generations converge and explore the world from ... their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and find ...
(Date:2/23/2017)... ... , ... Current Meditation , a new meditation concept ... U.S. starting this spring. Current Meditation focuses on “meditation for the modern world,” ... will be the first meditation concept in the U.S. offering franchising opportunities, setting ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Feb 24, 2017 Research and Markets has announced ... 2016" report to their offering. ... The latest research Hemophilia Drugs Price Analysis and Strategies - ... The research answers the following questions: ... How are they positioned in the Global Hemophilia market? ...
(Date:2/24/2017)... 24, 2017  In conjunction with DURECT Corporation,s (Nasdaq: ... press release, you are invited to listen to a ... internet on Tuesday, March 14, 2017 at 4:30 pm ... live audio webcast of the presentation will be available ... clicking "Investor Relations."  If you are unable to participate ...
(Date:2/24/2017)... Feb. 23, 2017 The U.S. Food ... PhenoTest BC Kit, performed on the Pheno System. ... that cause bloodstream infections and provide information about ... to (antibiotic sensitivity). The test also reduces the ... important information, which can guide antibiotic treatment recommendations ...
Breaking Medicine Technology: